Temaril-P

Kennel Cough Treatment for Dogs

Temaril-P is an antitussive, antipruritic, and anti-inflammatory
agent. The oral tablets treat coughing, itching, and inflammation associated
with a variety of conditions, including allergies and allergic skin
disorders. It is effective in most instances of coughing of nonspecific
origin, as well.

Temaril-P reduces inflammation, itching, and coughing
in dogs. It is useful for allergic conditions, kennel cough, colds,
bronchitis, and other illnesses accompanied by coughing. It can alleviate
itching from any cause, and is particularly useful for itching associated
with inflammatory conditions such as eczema, various types of dermatitis,
and otitis.

Benefits of Temaril-P:

Stops or reduces coughing from a number of causes

Treats skin inflammation

Remedies itchiness associated with dermatological
conditions and other causes

Eases your dog's suffering with symptom relief

Available as easily dosed scored oral tablets

Safe for use in dogs with acute or chronic bacterial
infections that are being treated with antibiotics

Follow all label instructions and heed precautionary
statements.

Use exactly as prescribed by your veterinarian.

Directions:

Administer Temaril-P with food to reduce the risk
of gastrointestinal upset.

Storage:

It is a violation of Federal
Law to use this product in a manner inconsistent with its labeling.

Warnings:

Keep Temaril-P out of reach of children and animals.
Do not use or store in or near open flame or heat.

Temaril-P is only intended for use in dogs. Do not
administer to other species. Do not use in any dog for which it was
not prescribed. Not for use in humans.

CAUTION: Federal law restricts this
drug to use by or on the order of a licensed veterinarian.

Temaril-P would not generally be effective at treating
coughs resulting from cardiac insufficiency.

Not for use in pregnant bitches. Tell your veterinarian
if your dog is lactating.

This product is not to be used in dogs with a hypersensitivity
to any of its ingredients. Labored breathing, facial swelling, hives,
rash, itching, sudden-onset diarrhea, vomiting, seizures, and shock
are some signs of an allergic reaction. Seek emergency veterinary treatment.

Do not give Temaril-P to any animal with a serious
viral or fungal infection. It may be used in animals with a bacterial
infection, provided the infection is being controlled with antibiotics.

This medication weakens the immune response and leaves
animals more vulnerable to infection. Take precautions to prevent infections.

Do not administer any vaccine to a dog being treated
with Temaril-P without your veterinarian's knowledge and involvement.

Tell your veterinarian if your dog has diabetes mellitus
or any other health problems.

Usage, especially prolonged, calls for a gradual
dose reduction, rather than an immediate cessation of therapy.

Temaril-P may cause gastrointestinal side effects.
The likelihood can be greatly reduced by administering doses with food.

Trimeprazine may cause drowsiness, muscle weakness,
and tremors. Prednisolone may cause increased hunger, thirst, or urination,
as well as diarrhea and emesis. Other side effects, including those
associated with use of any corticosteroid, may occur. Discuss any observed
adverse effects with your veterinarian.

Side effects are generally dose-related, and may
be successfully managed with a dosage reduction.

Temaril-P can interact with a number of drugs and
supplements. Tell your veterinarian if your dog takes any other medications
or supplements, and always consult your veterinarian before concurrently
administering any new ones during therapy with Temaril-P.

Some signs of an overdose include extreme drowsiness,
hypotension, and seizures. Seek emergency veterinary attention for a
known or suspected overdose.

Prednisolone overdose does not generally cause some
of the more obvious symptoms, such as sodium retention and edema, associated
with overdose of other corticosteroids. Monitor pets for blood dyscrasias
and increased thirst or urinary output.

All precautions associated with the use of cortisone
and phenothiazine derivatives apply to Temaril-P.